RecruitingNot ApplicableNCT05826925

Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy


Sponsor

University of Utah

Enrollment

30 participants

Start Date

Feb 27, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Cardiovascular disease is the leading cause of death among women in the United States, and women with hypertensive disorders of pregnancy have a 2-fold higher risk for cardiovascular disease later in life compared to women with uncomplicated pregnancies. This research investigates a patient-centered intervention during the postpartum period to promote engagement in cardiovascular preventive care.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria3

  • Delivered a pregnancy complicated by a hypertensive disorder of pregnancy at the University of Utah during the current hospital admission
  • Ability to speak and read English or Spanish
  • Written informed consent obtained

Exclusion Criteria2

  • Cardiovascular disease diagnosis (history of peripheral artery disease, stroke, or myocardial infarction)
  • Impairment of cognitive function or vision that prohibits communication and/or reading the decision aid.

Interventions

OTHERDecision aid

A decision aid will be developed based on qualitative data from Aim 1 and iterative refinement with input from stakeholders from Aim 2. Anticipated content includes: 1) information about cardiovascular risk following hypertensive disorders of pregnancy; 2) goal-setting exercises for blood pressure, weight management, glucose control, physical activity, and smoking cessation; 3) self-care steps to achieve management targets; 4) values clarification exercises to identify values related to cardiovascular risk management and identify priority areas for focus and improvement; and 5) discussion of how to communicate questions and goals of treatment to their provider.


Locations(1)

University of Utah Hospital

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05826925


Related Trials